Windlas Biotech Limited Strengthens Senior Management Capability

Windlas Biotech Limited, one of the top five players in the domestic pharmaceutical formulations contract development and manufacturing organization ("CDMO") industry in India has further strengthened the senior management capability with appointment of Mr. Shailendra Rastogi as a Chief Business Officer. He would be responsible for handling CDMO, Export, API & CRAMS business development for the company.

Brief Profile

- 22+ years of experience in Pharmaceutical Sales & Business Development.

- MBA Marketing from CSJM University, Kanpur, MSc - Chemistry from Lucknow University & Bachelor of Science from Lucknow University.

- Prior to joining Windlas Biotech Limited, he was associated with "Mehta API Private Ltd.", as an Associate Vice President (AVP) - Business Development. Prior to that he was associated with GVK Biosciences Pvt. Limited, Ind Swift laboratories Ltd, Parabolic Drugs Ltd, Syngene International Ltd. (Biocon Ltd) , Alembic Ltd., Merck Ltd. & AIMIL Ltd at various capacities in sales and business development.

"With his rich experience and a long track record of working with leading Pharmaceutical companies, Shailendra brings in lots of expertise and fresh insights to the table. His appointment has further strengthened the senior management team and would further sharpen the focus on strategic business development. I congratulate him on his new role and look forward to working with him to achieve our long term vision and goals" said Mr. Hitesh Windlass, Managing Director - Windlas Biotech.

Shares of Windlas Biotech Ltd was last trading in BSE at Rs. 264.55 as compared to the previous close of Rs. 261.65. The total number of shares traded during the day was 2521 in over 326 trades.

The stock hit an intraday high of Rs. 268.85 and intraday low of 255.50. The net turnover during the day was Rs. 668143.00.

Source : Equity Bulls

Keywords

WindlasBiotech ContractDevelopmentManufacturingOrganization CDMO Appointment